Dermorphin
Brain & neurobiology
PreclinicalEvidence is principally preclinical pharmacology and rodent analgesia.
Laboratory, computational, ex vivo or animal model research is the main evidence base.
What is Dermorphin?
Dermorphin is a naturally occurring amphibian opioid heptapeptide used in preclinical pharmacology and rodent analgesia research as a potent opioid receptor ligand; the catalogue entry denotes the research grade peptide.
Which research context has Dermorphin been associated with?
Dermorphin is associated with neuroscience and pharmacology research as a naturally derived opioid peptide principally investigated in preclinical receptor pharmacology and rodent analgesia models.
What documentation is available for Dermorphin?
Dermorphin: Batch documents are not yet linked on this site. For this naturally derived opioid peptide the checklist comprises batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and stated purity; peptide content and residual solvent/water details; and any functional assay or characterization data. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Dermorphin?
Dermorphin: Storage depends on the documented supplied presentation; for this naturally derived opioid peptide confirm dry/lyophilised versus solution supply, solvent or buffer composition, concentration, pH sensitivity, container closure compatibility and freeze/thaw behaviour to mitigate proteolysis, adsorption and chemical degradation. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.